Published online Aug 6, 2020. doi: 10.12998/wjcc.v8.i15.3249
Peer-review started: April 9, 2020
First decision: April 29, 2020
Revised: May 11, 2020
Accepted: July 14, 2020
Article in press: July 14, 2020
Published online: August 6, 2020
Processing time: 119 Days and 0.1 Hours
Glaucoma is an irreversible optic neuropathy with the loss of visual field and decrease of vision. A quick, user-friendly, and non-invasive method of assessing the anterior segment parameters is essential for early screening and diagnosis of glaucoma.
The main topic is to compare the difference between anterior chamber angle parameters measured by different methods.
To investigate the agreement, difference, and correlation of chamber angle parameters such as angel opening distance at 500 μm (AOD500) and trabeculo-iris space area at 500 μm2 (TISA500) measured by anterior segment optical coherence tomography (AS-OCT) and ultrasound biomicroscopy (UBM) in normal subjects.
Both AS-OCT and UBM were performed to measure AOD500 and TISA500 in 45 subjects (72 eyes). All subjects without glaucoma were collected from October 2015 to August 2016 at the Ophthalmology Department of the Fourth Affiliated Hospital of China Medical University. Data of the two groups (AOD500 and TISA500) were compared by nonparametric tests. Pearson correlative analysis and Bland–Altman analysis were used to compare the correlation and agreement.
There were no significant differences between AS-OCT and UBM in measuring AOD500 and TISA500 of the four quadrants of the anterior chamber angle. There was a high correlation in measuring AOD500 and TISA500. There was a good agreement in measuring AOD500 and TISA500.
There is a high correlation and agreement between AOD500 and TISA500 measurements by AS-OCT and UBM. They are interchangeable under some circumstances. AS-OCT proves to be a better early screening tool for glaucoma.
AS-OCT and UBM are interchangable for AOD500 and TISA500 measurements and cannot be completely replaced by each other. AS-OCT can be used as the first choice for early glaucoma screening, especially for primary open-angle glaucoma patients.